Skip to main content
SpringerLink
Log in
Book cover

Placebos and Nocebos in Headaches pp 43–55Cite as

Mechanisms of Placebo and Nocebo

  • Chapter
  • First Online:

Part of the book series: Headache ((HEAD))

Abstract

Placebo effects can be conceptualized as the beneficial effects triggered by the psychosocial treatment context. The nocebo effect is its negative counterpart. Over the last 30 years, the knowledge of placebo and nocebo effects has increased substantially. It has become evident that placebo and nocebo effects are interesting models to understand the intricate mind-body interaction. In addition, they are essential components of any medical setting. The psychological and neurobiological mechanisms underlying these phenomena are specified. In particular, psychological mechanisms are identified as mediators of placebo and nocebo responses; indeed, cognitive and emotional processes such as expectations, self-efficacy desires, anxiety, and somatic focus but also learning mechanisms can enhance or reduce the effectiveness of a medical treatment. Furthermore, the psychosocial context triggers a cascade of neurobiological changes in the brain. The study of these phenomena has important translational implications in the clinical setting.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci. 1999;19:484–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Amanzio M, Corazzini LL, Vase L, Benedetti F. A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain. 2009;146:261–9. https://doi.org/10.1016/j.pain.2009.07.010.

    Article  CAS  PubMed  Google Scholar 

  3. Amanzio M, Pollo A, Maggi G, Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001;90:205–15.

    Article  CAS  PubMed  Google Scholar 

  4. André-Obadia N, Magnin M, Garcia-Larrea L. On the importance of placebo timing in rTMS studies for pain relief. Pain. 2011;152:1233–7. https://doi.org/10.1016/j.pain.2010.12.027.

    Article  PubMed  Google Scholar 

  5. Aslaksen PM, Zwarg ML, Eilertsen H-IH, Gorecka MM, Bjørkedal E. Opposite effects of the same drug: reversal of topical analgesia by nocebo information. Pain. 2015;156:39–46. https://doi.org/10.1016/j.pain.0000000000000004.

    Article  PubMed  Google Scholar 

  6. Atlas LY, Whittington RA, Lindquist MA, Wielgosz J, Sonty N, Wager TD. Dissociable influences of opiates and expectations on pain. J Neurosci. 2012;32:8053–64. https://doi.org/10.1523/JNEUROSCI.0383-12.2012.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Autret A, Valade D, Debiais S. Placebo and other psychological interactions in headache treatment. J Headache Pain. 2012;13:191–8. https://doi.org/10.1007/s10194-012-0422-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. BALINT M. The doctor, his patient, and the illness. Lancet. 1955;268:683–8.

    Article  CAS  PubMed  Google Scholar 

  9. Benedetti F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain. 1996;64:535–43.

    Article  CAS  PubMed  Google Scholar 

  10. Benedetti F. Placebo effects: from the neurobiological paradigm to translational implications. Neuron. 2014;84:623–37. https://doi.org/10.1016/j.neuron.2014.10.023.

    Article  CAS  PubMed  Google Scholar 

  11. Benedetti F. Placebo effects. 2nd ed. Oxford: Oxford University Press; 2014.

    Book  Google Scholar 

  12. Benedetti F, Amanzio M, Casadio C, Oliaro A, Maggi G. Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain. 1997;71:135–40.

    Article  CAS  PubMed  Google Scholar 

  13. Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. Lancet. 1995;346:1231.

    Article  CAS  PubMed  Google Scholar 

  14. Benedetti F, Amanzio M, Rosato R, Blanchard C. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med. 2011;17:1228–30. https://doi.org/10.1038/nm.2435.

    Article  CAS  PubMed  Google Scholar 

  15. Benedetti F, Amanzio M, Thoen W. Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors. Psychopharmacology (Berl). 2011;213:791–7. https://doi.org/10.1007/s00213-010-2037-y.

    Article  CAS  Google Scholar 

  16. Benedetti F, Amanzio M, Vighetti S, Asteggiano G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci. 2006;26:12014–22. https://doi.org/10.1523/JNEUROSCI.2947-06.2006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Benedetti F, Arduino C, Amanzio M. Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci. 1999;19:3639–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects. Lancet Neurol. 2016;15:736–47. https://doi.org/10.1016/S1474-4422(16)00066-1.

    Article  PubMed  Google Scholar 

  19. Benedetti F, Carlino E, Pollo A. How placebos change the patient’s brain. Neuropsychopharmacology. 2011;36:339–54. https://doi.org/10.1038/npp.2010.81.

    Article  PubMed  Google Scholar 

  20. Benedetti F, Carlino E, Pollo A. Hidden administration of drugs. Clin Pharmacol Ther. 2011;90:651–61. https://doi.org/10.1038/clpt.2011.206.

    Article  CAS  PubMed  Google Scholar 

  21. Benedetti F, Maggi G, Lopiano L, Lanotte M, Rainero I, Vighetti S, Pollo A. Open versus hidden medical treatments: the patient’s knowledge about a therapy affects the therapy outcome. Prev Treat. 2003;6. https://doi.org/10.1037/1522-3736.6.1.61a.

  22. Bingel U. Avoiding nocebo effects to optimize treatment outcome. JAMA. 2014;312:693–4. https://doi.org/10.1001/jama.2014.8342.

    Article  CAS  PubMed  Google Scholar 

  23. Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, Tracey I. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med. 2011;3:70ra14. https://doi.org/10.1126/scitranslmed.3001244.

    Article  CAS  PubMed  Google Scholar 

  24. Di BZ, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet. 2001;357:757–62. https://doi.org/10.1016/S0140-6736(00)04169-6.

    Article  Google Scholar 

  25. Branthwaite A, Cooper P. Analgesic effects of branding in treatment of headaches. Br Med J (Clin Res Ed). 1981;282:1576–8.

    Article  CAS  Google Scholar 

  26. Büchel C, Geuter S, Sprenger C, Eippert F. Placebo analgesia: a predictive coding perspective. Neuron. 2014;81:1223–39. https://doi.org/10.1016/j.neuron.2014.02.042.

    Article  CAS  PubMed  Google Scholar 

  27. Carlino E, Benedetti F. Placebo and nocebo effects. In: Mostofsky DI, editor. The handbook of behavioral medicine. 2014. p. 36–57. https://doi.org/10.1002/9781118453940.ch3.

    Chapter  Google Scholar 

  28. Carlino E, Benedetti F. Different contexts, different pains, different experiences. Neuroscience. 2016;338:19–26. https://doi.org/10.1016/j.neuroscience.2016.01.053.

    Article  CAS  PubMed  Google Scholar 

  29. Carlino E, Guerra G, Piedimonte A. Placebo effects: from pain to motor performance. Neurosci Lett. 2016;632:224–30. https://doi.org/10.1016/j.neulet.2016.08.046.

    Article  CAS  PubMed  Google Scholar 

  30. Carlino E, Torta D, Piedimonte A, Frisaldi E, Vighetti S, Benedetti F. Role of explicit verbal information in conditioned analgesia. Eur J Pain. 2015;19:546–53. https://doi.org/10.1002/ejp.579.

    Article  CAS  PubMed  Google Scholar 

  31. Chavarria V, Vian J, Pereira C, Data-Franco J, Fernandes BS, Berk M, Dodd S. The placebo and nocebo phenomena: their clinical management and impact on treatment outcomes. Clin Ther. 2017;39:477–86. https://doi.org/10.1016/j.clinthera.2017.01.031.

    Article  PubMed  Google Scholar 

  32. Chua P, Krams M, Toni I, Passingham R, Dolan R. A functional anatomy of anticipatory anxiety. Neuroimage. 1999;9:563–71. https://doi.org/10.1006/nimg.1999.0407.

    Article  CAS  PubMed  Google Scholar 

  33. Colagiuri B, Quinn VF. Autonomic arousal as a mechanism of the persistence of nocebo hyperalgesia. J Pain. 2018;19:476–86. https://doi.org/10.1016/j.jpain.2017.12.006.

    Article  PubMed  Google Scholar 

  34. Colloca L, Benedetti F. How prior experience shapes placebo analgesia. Pain. 2006;124:126–33. https://doi.org/10.1016/j.pain.2006.04.005.

    Article  PubMed  Google Scholar 

  35. Colloca L, Benedetti F. Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol. 2007;20:435–9. https://doi.org/10.1097/ACO.0b013e3282b972fb.

    Article  PubMed  Google Scholar 

  36. Colloca L, Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA. 2012;307:567–8. https://doi.org/10.1001/jama.2012.115.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Colloca L, Grillon C. Understanding placebo and nocebo responses for pain management. Curr Pain Headache Rep. 2014;18:419. https://doi.org/10.1007/s11916-014-0419-2.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurol. 2004;3:679–84. https://doi.org/10.1016/S1474-4422(04)00908-1.

    Article  PubMed  Google Scholar 

  39. Colloca L, Miller FG. How placebo responses are formed: a learning perspective. Philos Trans R Soc Lond Ser B Biol Sci. 2011;366:1859–69. https://doi.org/10.1098/rstb.2010.0398.

    Article  Google Scholar 

  40. Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F. How the number of learning trials affects placebo and nocebo responses. Pain. 2010;151:430–9. https://doi.org/10.1016/j.pain.2010.08.007.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Colloca L, Sigaudo M, Benedetti F. The role of learning in nocebo and placebo effects. Pain. 2008;136:211–8. https://doi.org/10.1016/j.pain.2008.02.006.

    Article  CAS  PubMed  Google Scholar 

  42. Colloca L, Tinazzi M, Recchia S, Le Pera D, Fiaschi A, Benedetti F, Valeriani M. Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain. 2008;139:306–14. https://doi.org/10.1016/j.pain.2008.04.021.

    Article  PubMed  Google Scholar 

  43. de Craen AJ, Tijssen JG, de Gans J, Kleijnen J. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol. 2000;247:183–8.

    Article  PubMed  Google Scholar 

  44. Dodd S, Dean OM, Vian J, Berk M. A review of the theoretical and biological understanding of the nocebo and placebo phenomena. Clin Ther. 2017;39:469–76. https://doi.org/10.1016/j.clinthera.2017.01.010.

    Article  PubMed  Google Scholar 

  45. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, Büchel C. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron. 2009;63:533–43. https://doi.org/10.1016/j.neuron.2009.07.014.

    Article  CAS  PubMed  Google Scholar 

  46. Ellerbrock I, Wiehler A, Arndt M, May A. Nocebo context modulates long-term habituation to heat pain and influences functional connectivity of the operculum. Pain. 2015;156:2222–33. https://doi.org/10.1097/j.pain.0000000000000297.

    Article  PubMed  Google Scholar 

  47. Enck P, Klosterhalfen S, Weimer K, Horing B, Zipfel S. The placebo response in clinical trials: more questions than answers. Philos Trans R Soc B Biol Sci. 2011;366:1889–95. https://doi.org/10.1098/rstb.2010.0384.

    Article  Google Scholar 

  48. Frisaldi E, Piedimonte A, Benedetti F. Placebo and nocebo effects: a complex interplay between psychological factors and neurochemical networks. Am J Clin Hypn. 2015;57:267–84. https://doi.org/10.1080/00029157.2014.976785.

    Article  PubMed  Google Scholar 

  49. Goebel MU, Trebst AE, Steiner J, Xie YF, Exton MS, Frede S, Canbay AE, Michel MC, Heemann U, Schedlowski M. Behavioral conditioning of immunosuppression is possible in humans. FASEB J. 2002;16:1869–73. https://doi.org/10.1096/fj.02-0389com.

    Article  CAS  PubMed  Google Scholar 

  50. Gupta U, Verma M. Placebo in clinical trials. Perspect Clin Res. 2013;4:49–52. https://doi.org/10.4103/2229-3485.106383.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Hashmi JA, Baria AT, Baliki MN, Huang L, Schnitzer TJ, Apkarian AV. Brain networks predicting placebo analgesia in a clinical trial for chronic back pain. Pain. 2012;153:2393–402. https://doi.org/10.1016/j.pain.2012.08.008.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Huneke NTM, Brown CA, Burford E, Watson A, Trujillo-Barreto NJ, El-Deredy W, AKP J. Experimental placebo analgesia changes resting-state alpha oscillations. PLoS One. 2013;8:1–11. https://doi.org/10.1371/journal.pone.0078278.

    Article  CAS  Google Scholar 

  53. Jensen KB, Kaptchuk TJ, Kirsch I, Raicek J, Lindstrom KM, Berna C, Gollub RL, Ingvar M, Kong J. Nonconscious activation of placebo and nocebo pain responses. Proc Natl Acad Sci U S A. 2012;109:15959–64. https://doi.org/10.1073/pnas.1202056109.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, Kirsch I, Schyner RN, Nam BH, Nguyen LT, Park M, Rivers AL, McManus C, Kokkotou E, Drossman DA, Goldman P, Lembo AJ. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ. 2008;336:999–1003. https://doi.org/10.1136/bmj.39524.439618.25.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Keltner JR, Furst A, Fan C, Redfern R, Inglis B, Fields HL. Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study. J Neurosci. 2006;26:4437–43. https://doi.org/10.1523/JNEUROSCI.4463-05.2006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Kessner S, Wiech K, Forkmann K, Ploner M, Bingel U. The effect of treatment history on therapeutic outcome: an experimental approach. JAMA Intern Med. 2013;173:1468–9. https://doi.org/10.1001/jamainternmed.2013.6705.

    Article  PubMed  Google Scholar 

  57. Kirsch I, Wickless C, Moffitt KH. Expectancy and suggestibility: are the effects of environmental enhancement due to detection? Int J Clin Exp Hypn. 1999;47:40–5. https://doi.org/10.1080/00207149908410021.

    Article  CAS  PubMed  Google Scholar 

  58. Klinger R, Soost S, Flor H, Worm M. Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin. Pain. 2007;128:31–9. https://doi.org/10.1016/j.pain.2006.08.025.

    Article  PubMed  Google Scholar 

  59. Kong J, Benedetti F. Placebo and nocebo effects: an introduction to psychological and biological mechanisms. Handb Exp Pharmacol. 2014;225:3–15. https://doi.org/10.1007/978-3-662-44519-8_1.

    Article  PubMed  Google Scholar 

  60. Kong J, Gollub RL, Polich G, Kirsch I, Laviolette P, Vangel M, Rosen B, Kaptchuk TJ. A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J Neurosci. 2008;28:13354–62. https://doi.org/10.1523/JNEUROSCI.2944-08.2008.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Kong J, Gollub RL, Rosman IS, Webb JM, Vangel MG, Kirsch I, Kaptchuk TJ. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci. 2006;26:381–8. https://doi.org/10.1523/JNEUROSCI.3556-05.2006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Koyama T, McHaffie JG, Laurienti PJ, Coghill RC. The subjective experience of pain: where expectations become reality. Proc Natl Acad Sci U S A. 2005;102:12950–5. https://doi.org/10.1073/pnas.0408576102.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Koyama T, Tanaka YZ, Mikami A. Nociceptive neurons in the macaque anterior cingulate activate during anticipation of pain. Neuroreport. 1998;9:2663–7.

    Article  CAS  PubMed  Google Scholar 

  64. Levine JD, Gordon NC. Influence of the method of drug administration on analgesic response. Nature. 1984;312:755–6.

    Article  CAS  PubMed  Google Scholar 

  65. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet. 1978;2:654–7.

    Article  CAS  PubMed  Google Scholar 

  66. Levine JD, Gordon NC, Smith R, Fields HL. Analgesic responses to morphine and placebo in individuals with postoperative pain. Pain. 1981;10:379–89.

    Article  CAS  PubMed  Google Scholar 

  67. Li L, Wang H, Ke X, Liu X, Yuan Y, Zhang D, Xiong D, Qiu Y. Placebo analgesia changes alpha oscillations induced by tonic muscle pain: EEG frequency analysis including data during pain evaluation. Front Comput Neurosci. 2016;10:45. https://doi.org/10.3389/fncom.2016.00045.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Lieberman MD, Jarcho JM, Berman S, Naliboff BD, Suyenobu BY, Mandelkern M, Mayer EA. The neural correlates of placebo effects: a disruption account. Neuroimage. 2004;22:447–55. https://doi.org/10.1016/j.neuroimage.2004.01.037.

    Article  PubMed  Google Scholar 

  69. Lui F, Colloca L, Duzzi D, Anchisi D, Benedetti F, Porro CA. Neural bases of conditioned placebo analgesia. Pain. 2010;151:816–24. https://doi.org/10.1016/j.pain.2010.09.021.

    Article  PubMed  Google Scholar 

  70. Meissner K, Bingel U, Colloca L, Wager TD, Watson A, Flaten MA. The placebo effect: advances from different methodological approaches. J Neurosci. 2011;31:16117–24. https://doi.org/10.1523/JNEUROSCI.4099-11.2011.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Montgomery G, Kirsch I. Mechanisms of placebo pain reduction: an empirical investigation. Psychol Sci. 1996;7:174–6. https://doi.org/10.1111/j.1467-9280.1996.tb00352.x.

    Article  Google Scholar 

  72. Morton DL, C a B, Watson A, El-Deredy W, Jones AKP. Cognitive changes as a result of a single exposure to placebo. Neuropsychologia. 2010;48:1958–64. https://doi.org/10.1016/j.neuropsychologia.2010.03.016.

    Article  PubMed  Google Scholar 

  73. Palermo S, Benedetti F, Costa T, Amanzio M. Pain anticipation: an activation likelihood estimation meta-analysis of brain imaging studies. Hum Brain Mapp. 2015;36:1648–61. https://doi.org/10.1002/hbm.22727.

    Article  PubMed  Google Scholar 

  74. Peciña M, Martínez-Jauand M, Hodgkinson C, Stohler CS, Goldman D, Zubieta JK. FAAH selectively influences placebo effects. Mol Psychiatry. 2014;19:385–91. https://doi.org/10.1038/mp.2013.124.

    Article  CAS  PubMed  Google Scholar 

  75. Petrovic P, Kalso E, Petersson KM, Andersson J, Fransson P, Ingvar M. A prefrontal non-opioid mechanism in placebo analgesia. Pain. 2010;150:59–65. https://doi.org/10.1016/j.pain.2010.03.011.

    Article  PubMed  Google Scholar 

  76. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia—imaging a shared neuronal network. Science. 2002;295:1737–40. https://doi.org/10.1126/science.1067176.

    Article  CAS  PubMed  Google Scholar 

  77. Piedimonte A, Guerra G, Vighetti S, Carlino E. Measuring expectation of pain: contingent negative variation in placebo and nocebo effects. Eur J Pain. 2017;21:874–85. https://doi.org/10.1002/ejp.990.

    Article  CAS  PubMed  Google Scholar 

  78. Ploghaus A, Tracey I, Gati JS, Clare S, Menon RS, Matthews PM, Rawlins JN. Dissociating pain from its anticipation in the human brain. Science. 1999;284:1979–81.

    Article  CAS  PubMed  Google Scholar 

  79. Pollo A, Amanzio M, Arslanian A, Casadio C, Maggi G, Benedetti F. Response expectancies in placebo analgesia and their clinical relevance. Pain. 2001;93:77–84.

    Article  CAS  PubMed  Google Scholar 

  80. Porro CA, Baraldi P, Pagnoni G, Serafini M, Facchin P, Maieron M, Nichelli P. Does anticipation of pain affect cortical nociceptive systems? J Neurosci. 2002;22:3206–14. doi: 20026310

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Porro CA, Cettolo V, Francescato MP, Baraldi P. Functional activity mapping of the mesial hemispheric wall during anticipation of pain. Neuroimage. 2003;19:1738–47.

    Article  PubMed  Google Scholar 

  82. Price DD, Craggs J, Verne GN, Perlstein WM, Robinson ME. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain. 2007;127:63–72. https://doi.org/10.1016/j.pain.2006.08.001.

    Article  PubMed  Google Scholar 

  83. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59:565–90. https://doi.org/10.1146/annurev.psych.59.113006.095941.

    Article  PubMed  Google Scholar 

  84. Price DD, Milling LS, Kirsch I, Duff A, Montgomery GH, Nicholls SS. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain. 1999;83:147–56.

    Article  CAS  PubMed  Google Scholar 

  85. Rescorla RA. Pavlovian conditioning: it’s not what you think it is. Am Psychol. 1988;43(3):151–60.

    Article  CAS  PubMed  Google Scholar 

  86. Rossetti G, Carlino E, Testa M. Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain. BMC Musculoskelet Disord. 2017;19:27.

    Article  Google Scholar 

  87. Sawamoto N, Honda M, Okada T, Hanakawa T, Kanda M, Fukuyama H, Konishi J, Shibasaki H. Expectation of pain enhances responses to nonpainful somatosensory stimulation in the anterior cingulate cortex and parietal operculum/posterior insula: an event-related functional magnetic resonance imaging study. J Neurosci. 2000;20:7438–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Schmid J, Bingel U, Ritter C, Benson S, Schedlowski M, Gramsch C, Forsting M, Elsenbruch S. Neural underpinnings of nocebo hyperalgesia in visceral pain: a fMRI study in healthy volunteers. Neuroimage. 2015;120:114–22. https://doi.org/10.1016/j.neuroimage.2015.06.060.

    Article  PubMed  Google Scholar 

  89. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta J-K. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron. 2007;55:325–36. https://doi.org/10.1016/j.neuron.2007.06.028.

    Article  CAS  PubMed  Google Scholar 

  90. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta J-K. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry. 2008;65:220–31. https://doi.org/10.1001/archgenpsychiatry.2007.34.

    Article  PubMed  Google Scholar 

  91. Sevel LS, Craggs JG, Price DD, Staud R, Robinson ME. Placebo analgesia enhances descending pain-related effective connectivity: a dynamic causal modeling study of endogenous pain modulation. J Pain. 2015;16:760–8. https://doi.org/10.1016/j.jpain.2015.05.001.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Sevel LS, O’Shea AM, Letzen JE, Craggs JG, Price DD, Robinson ME. Effective connectivity predicts future placebo analgesic response: a dynamic causal modeling study of pain processing in healthy controls. Neuroimage. 2015;110:87–94. https://doi.org/10.1016/j.neuroimage.2015.01.056.

    Article  PubMed  Google Scholar 

  93. Testa M, Rossettini G. Enhance placebo, avoid nocebo: how contextual factors affect physiotherapy outcomes. Man Ther. 2016;24:65–74. https://doi.org/10.1016/j.math.2016.04.006.

    Article  PubMed  Google Scholar 

  94. Tétreault P, Mansour A, Vachon-Presseau E, Schnitzer TJ, Apkarian AV, Baliki MN. Brain connectivity predicts placebo response across chronic pain clinical trials. PLoS Biol. 2016;14:e1002570. https://doi.org/10.1371/journal.pbio.1002570.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med. 2010;16:1277–83. https://doi.org/10.1038/nm.2229.

    Article  CAS  PubMed  Google Scholar 

  96. Varelmann D, Pancaro C, Cappiello EC, Camann WR. Nocebo-induced hyperalgesia during local anesthetic injection. Anesth Analg. 2010;110:868–70. https://doi.org/10.1213/ANE.0b013e3181cc5727.

    Article  CAS  PubMed  Google Scholar 

  97. Vase L, Amanzio M, Price DD. Nocebo vs. placebo: the challenges of trial design in analgesia research. Clin Pharmacol Ther. 2015;97:143–50. https://doi.org/10.1002/cpt.31.

    Article  CAS  PubMed  Google Scholar 

  98. Vase L, Robinson ME, Verne GN, Price DD. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain. 2005;115:338–47. https://doi.org/10.1016/j.pain.2005.03.014.

    Article  PubMed  Google Scholar 

  99. Voudouris NJ, Peck CL, Coleman G. The role of conditioning and verbal expectancy in the placebo response. Pain. 1990;43:121–8.

    Article  CAS  PubMed  Google Scholar 

  100. Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci. 2015;16:403–18. https://doi.org/10.1038/nrn3976.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Wager TD, Atlas LY, Leotti LA, Rilling JK. Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience. J Neurosci. 2011;31:439–52. https://doi.org/10.1523/JNEUROSCI.3420-10.2011.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Wager TD, Matre D, Casey KL. Placebo effects in laser-evoked pain potentials. Brain Behav Immun. 2006;20:219–30. https://doi.org/10.1016/j.bbi.2006.01.007.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science. 2004;303:1162–7. https://doi.org/10.1126/science.1093065.

    Article  CAS  PubMed  Google Scholar 

  104. Wager TD, Scott DJ, Zubieta J-K. Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A. 2007;104:11056–61. https://doi.org/10.1073/pnas.0702413104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Wampold B. The therapeutic value of the relationship in the placebo effect and other healing practices, vol. 139; 2018. p. 191–210.

    Google Scholar 

  106. Wickramasekera I. A conditioned response model of the placebo effect predictions from the model. Biofeedback Self Regul. 1980;5:5–18.

    Article  CAS  PubMed  Google Scholar 

  107. Zubieta J-K. Placebo effects mediated by endogenous opioid activity on -opioid receptors. J Neurosci. 2005;25:7754–62. https://doi.org/10.1523/JNEUROSCI.0439-05.2005.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Zubieta J-K, Stohler CS. Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci. 2009;1156:198–210. https://doi.org/10.1111/j.1749-6632.2009.04424.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Zunhammer M, Ploner M, Engelbrecht C, Bock J, Kessner SS, Bingel U. The effects of treatment failure generalize across different routes of drug administration. Sci Transl Med. 2017;9:eaal2999. https://doi.org/10.1126/scitranslmed.aal2999.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuroscience, University of Turin Medical School, Turin, Italy

    Elisa Carlino & Alessandro Piedimonte

  2. Department of Psychology and Behavioural Sciences, School of Business and Social Sciences, Aarhus University, Aarhus, Denmark

    Lene Vase

Authors
  1. Elisa Carlino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lene Vase
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessandro Piedimonte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elisa Carlino .

Editor information

Editors and Affiliations

  1. Neurology Department, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece

    Dimos D. Mitsikostas

  2. Neuroscience Department, University of Turin Medical School, Torino, Italy

    Fabrizio Benedetti

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Carlino, E., Vase, L., Piedimonte, A. (2019). Mechanisms of Placebo and Nocebo. In: Mitsikostas, D., Benedetti, F. (eds) Placebos and Nocebos in Headaches. Headache. Springer, Cham. https://doi.org/10.1007/978-3-030-02976-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-02976-0_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-02975-3

  • Online ISBN: 978-3-030-02976-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation